Quest Diagnostics
DGX
#1079
Rank
โ‚น1.850 T
Marketcap
โ‚น16,549
Share price
0.86%
Change (1 day)
23.67%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Revenue for Quest Diagnostics (DGX)

Revenue in 2025 (TTM): โ‚น938.33 Billion

According to Quest Diagnostics 's latest financial reports the company's current revenue (TTM ) is โ‚น974.90 Billion. In 2024 the company made a revenue of โ‚น846.88 Billion an increase over the revenue in the year 2023 that were of โ‚น770.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Quest Diagnostics from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น938.33 B10.8%
2024 โ‚น846.88 B9.95%
2023 โ‚น770.21 B-5.82%
2022 โ‚น817.81 B1.85%
2021 โ‚น802.96 B16.34%
2020 โ‚น690.16 B25.27%
2019 โ‚น550.94 B4.63%
2018 โ‚น526.58 B10.36%
2017 โ‚น477.15 B-6.56%
2016 โ‚น510.68 B2.56%
2015 โ‚น497.94 B5.67%
2014 โ‚น471.21 B6.73%
2013 โ‚น441.50 B10.51%
2012 โ‚น399.51 B0.56%
2011 โ‚น397.30 B20.32%
2010 โ‚น330.20 B-4.54%
2009 โ‚น345.92 B-0.72%
2008 โ‚น348.44 B32.42%
2007 โ‚น263.13 B-5.22%
2006 โ‚น277.63 B12.32%
2005 โ‚น247.18 B11.33%
2004 โ‚น222.02 B2.92%
2003 โ‚น215.71 B9.5%
2002 โ‚น196.99 B12.54%
2001 โ‚น175.04 B9.63%
2000 โ‚น159.67 B66.56%
1999 โ‚น95.86 B54.57%
1998 โ‚น62.01 B3.24%
1997 โ‚น60.07 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
LabCorp
LH
โ‚น1.236 T 26.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚น1.76 B-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น63.72 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น2.46 B-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น20.22 B-97.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น186.06 B-80.91%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands